Is it LDL particle size or number that correlates with risk for cardiovascular disease?

Current Atherosclerosis Reports
H Robert Superko, Radhika R Gadesam

Abstract

The role of low-density lipoprotein cholesterol (LDL-C) in the pathogenesis of cardiovascular disease (CVD) and the clinical benefit of lowering LDL-C in high-risk patients is well established. What remains controversial is whether we are using the best measure(s) of LDL characteristics to identify all individuals who are at CVD risk or if they would benefit from specific therapies. Despite the successful LDL-C reduction trials, substantial numbers of patients continue to have clinical events in the treatment groups. The size of LDL particles and assessment of the number of LDL particles (LDL-Num) have been suggested as a more reliable method of atherogenicity. Each LDL particle has one apoprotein B-100 measure attached; therefore, determination of whole plasma apoprotein B can be considered the best measure of LDL-Num. Because the cholesterol content per LDL particle exhibits large interindividual variation, the information provided by LDL-C and LDL-Num is not equivalent. Individuals with the same level of LDL-C may have higher or lower numbers of LDL particles and, as a result, may differ in terms of absolute CVD risk. LDL particle size and number provide independent measures of atherogenicity and are strong predictors of CVD.

Associated Clinical Trials

References

Jan 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·P M NishinaR M Krauss
Oct 7, 1988·JAMA : the Journal of the American Medical Association·M A AustinR M Krauss
Jan 1, 1986·Methods in Enzymology·A V NicholsT A Musliner
Oct 1, 1966·Circulation·J W GofmanR Tandy
Oct 1, 1994·Current Opinion in Lipidology·R M Krauss
May 14, 1993·Biochemical and Biophysical Research Communications·B WeisserW Vetter
Sep 18, 1996·JAMA : the Journal of the American Medical Association·C D GardnerR M Krauss
Sep 18, 1996·JAMA : the Journal of the American Medical Association·M J StampferC H Hennekens
Apr 4, 1998·The American Journal of Cardiology·R M Krauss
Nov 13, 1999·Arteriosclerosis, Thrombosis, and Vascular Biology·L MykkänenM A Austin
Oct 29, 2000·The American Journal of Cardiology·P Cullen
Dec 21, 2000·Current Atherosclerosis Reports·H R Superko
Mar 7, 2001·Frontiers in Bioscience : a Journal and Virtual Library·R H Superko
Sep 27, 2001·JAMA : the Journal of the American Medical Association·H CamposF M Sacks
Jul 16, 2002·Arteriosclerosis, Thrombosis, and Vascular Biology·Lewis KullerRichard Kronmal
Aug 13, 2002·European Journal of Human Genetics : EJHG·Juha VakkilainenMarja-Riitta Taskinen
Sep 18, 2002·Journal of Lipid Research·Kaspar K Berneis, Ronald M Krauss
Nov 7, 2002·The American Journal of Cardiology·James D OtvosWilliam C Cromwell
Feb 18, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Paul T WilliamsRonald M Krauss
Apr 11, 2003·Current Treatment Options in Cardiovascular Medicine·H. Robert Superko, Nicolas A. Chronos
Oct 15, 2003·The Journal of Clinical Endocrinology and Metabolism·Frank M Sacks, Hannia Campos
May 29, 2004·Current Opinion in Lipidology·Aaron T Lada, Lawrence L Rudel
Aug 7, 2004·Current Atherosclerosis Reports·William C Cromwell, James D Otvos
Dec 24, 2005·QJM : Monthly Journal of the Association of Physicians·M Rizzo, K Berneis

❮ Previous
Next ❯

Citations

Aug 14, 2012·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·L BredaA Mohn
Oct 1, 2010·The British Journal of Nutrition·Krista A VaradyBenoît Lamarche
May 30, 2009·Vascular Health and Risk Management·Naila Goldenberg, Charles Glueck
Oct 1, 2014·The British Journal of Nutrition·Frank ThiesPenny Kris-Etherton
Jul 11, 2009·Cellular and Molecular Life Sciences : CMLS·Doriane RichardFrancesco Visioli
Feb 11, 2015·Clinica Chimica Acta; International Journal of Clinical Chemistry·J MartinsT S Pillay
May 1, 2010·Atherosclerosis·Zeynep OzbalkanManfredi Rizzo
Sep 5, 2012·Acta Psychiatrica Scandinavica·X FanD C Henderson
Mar 2, 2012·Clinical and Translational Science·Kyle J DiehlChristopher A DeSouza
Apr 18, 2014·Clinical and Experimental Pharmacology & Physiology·Rui-Xia XuJian-Jun Li
Dec 22, 2012·Journal of the American College of Cardiology·Jennifer G Robinson
Sep 24, 2009·The Journal of Pediatrics·Osamu ArisakaNaoto Shimura
Oct 22, 2010·Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition·Richard Kones
Jun 26, 2017·Journal of Medical Case Reports·Mahfouz Al-Bachir, Mohamad Adel Bakir
Apr 23, 2017·Current Cardiology Reports·Morton LeibowitzRan D Balicer
Feb 8, 2018·Nutrition & Dietetics : the Journal of the Dietitians Association of Australia·Kelsey E MillerEric P Plaisance
Jan 27, 2019·Scientific Reports·Juho-Pekka KarjalainenTerho Lehtimäki
Dec 19, 2017·Epilepsy & Behavior : E&B·Tanya J W McDonaldMackenzie C Cervenka
Jun 6, 2017·Toxicon : Official Journal of the International Society on Toxinology·Patricia Lucio AlvesPaulo Flavio Silveira
Jul 30, 2010·Journal of Colloid and Interface Science·Michael J Walters, Steven P Wrenn

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.